Pemetrexed-induced cutaneous sclerosis of the lower limbs
- 1 December 2020
- journal article
- research article
- Published by Elsevier BV in Annales de Dermatologie et de Vénéréologie
- Vol. 147 (12), 842-847
- https://doi.org/10.1016/j.annder.2020.06.016
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Skin Toxicities Compromise Prolonged Pemetrexed TreatmentJournal of Thoracic Oncology, 2011
- Painful generalized erythematous patches: A severe and unusual cutaneous reaction to pemetrexedJournal of the American Academy of Dermatology, 2011
- Revisiting cutaneous adverse reactions to pemetrexedOncology Letters, 2011
- A Case Series of Dose-Limiting Peripheral Edema Observed in Patients Treated with PemetrexedJournal of Thoracic Oncology, 2011
- Approval Summary: Pemetrexed Maintenance Therapy of Advanced/Metastatic Nonsquamous, Non-Small Cell Lung Cancer (NSCLC)The Oncologist, 2010
- Pemetrexed-Induced Fluid RetentionJournal of Thoracic Oncology, 2010
- Acute generalized exanthematous pustulosis after pemetrexed, and recurrence after re-introductionClinical and Experimental Dermatology, 2009
- Pemetrexed-associated urticarial vasculitisLung Cancer, 2006
- Gemcitabine-associated scleroderma-like changes of the lower extremitiesJournal of the American Academy of Dermatology, 2004
- Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With ChemotherapyJournal of Clinical Oncology, 2004